This is a news story, published by CNBC, that relates primarily to Merck news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
blockbuster cancer drug Keytruda. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest key drug launches news, Keytruda sales news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
ongoing Medicare drug price negotiationsCNBC
•89% Informative
Merck reported $16.11 billion in revenue for the second quarter , up 7% from the same period a year ago .
The pharmaceutical giant also raised its full-year sales forecast to a range of $63.4 billion to $64.4billion .
The results come as Merck prepares to offset losses from Keytruda 's patent expiration in 2028 with a handful of new deals under its belt and key drug launches.
Winrevair, a medication approved in March to treat a progressive and life-threatening lung condition, was released in March .
Still, that topped analysts' expectations of $81.5 million in sales, according to StreetAccount . Merck 's animal health division, which develops vaccines and medicines for dogs, cats and cattle, posted $1.48 billion in sales for the second quarter . That is up 2% from the year-earlier period and slightly below what analysts surveyed by StreetAccount were expecting..
VR Score
94
Informative language
97
Neutral language
40
Article tone
formal
Language
English
Language complexity
44
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
6
Source diversity
4
Affiliate links
no affiliate links